Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/20/2014US20140079729 Method for improving endothelial function and decreasing cardiovascular morbidity using shilajit
03/20/2014US20140079723 Therapeutic Compositions and Associated Methods
03/20/2014US20140079722 Extracellular targeted drug conjugates
03/20/2014US20140079720 Inhibitors of extracellular hsp90
03/20/2014US20140079718 Mast cell markers and prevention, diagnosis, and therapy for chronic pelvic pain syndrome
03/20/2014US20140079712 Therapeutic Applications Targeting SARM1
03/20/2014US20140079703 Combination therapies comprising anti-erbb3 agents
03/20/2014US20140079694 Cai-based systems and methods for the localized treatment of ocular and other diseases
03/20/2014US20140079693 Kinase inhibitors and methods of their use
03/20/2014US20140079692 Dosages for treatment with anti-egfr antibodies
03/20/2014US20140079690 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
03/20/2014US20140079685 Method and composition for treating a serotonin receptor-mediated condition
03/20/2014US20140079680 Melatonin-based treatment and diagnosis of bile duct disease
03/20/2014US20140079679 Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
03/20/2014US20140079667 Tetrazolones as inhibitors of fatty acid synthase
03/20/2014US20140079666 Pyrimidinone compounds and methods for preventing and treating influenza
03/20/2014US20140079665 Therapeutic anti-igf1r combinations
03/20/2014US20140079662 Compositions and methods for treating respiratory disorders with doxofilline
03/20/2014US20140079657 Topical compositions and methods of use
03/20/2014US20140079646 Pharmaceutical formulation for treating the upper digestive tract
03/20/2014US20140079644 Cellulose-based nanoparticles for drug delivery
03/20/2014US20140079642 Nanoparticles based for dermal and systemic delivery of drugs
03/20/2014US20140079636 Targeted therapeutics
03/20/2014US20140079631 Anti-inflammatory particles
03/20/2014DE202013010620U1 Getränk Beverage
03/20/2014DE202013010617U1 Getränk Beverage
03/20/2014DE202013010615U1 Getränk Beverage
03/20/2014DE202013010613U1 Getränk Beverage
03/20/2014DE202013010612U1 Getränk Beverage
03/20/2014DE112011105169T5 Neue pharmazeutische Zusammensetzung mit geringen Nebenwirkungen enthaltend anti-Tuberkulose Arzneimittel New pharmaceutical composition with minimal side effects including anti-tuberculosis drugs
03/19/2014EP2708601A1 Treatment of heart disease through modulation of hypoxia induced eRNA activity
03/19/2014EP2708548A2 High-Purity Rebaudioside D and Applications
03/19/2014EP2708540A1 Pyrimido-diazepinone compound
03/19/2014EP2708539A1 Annulated pyrimidines and triazines and their use
03/19/2014EP2708538A1 Process for preparing fused pyrimidine-dione derivatives, useful as as TRPA1 modulators
03/19/2014EP2708537A1 Heteroaromatic ring derivative
03/19/2014EP2708535A1 Agents for treating disorders involving modulation of ryanodine receptors
03/19/2014EP2708534A1 Thiazole compound and preparation method and use thereof
03/19/2014EP2708532A1 4-aminoquinazoline derivatives and uses thereof
03/19/2014EP2708531A1 Crystalline Forms Of 3-[5-Chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydroxyethyl)-4-methylbenzamide
03/19/2014EP2708264A2 Cosmetic two component preparation
03/19/2014EP2708256A2 Device and method for delivery of a medicament
03/19/2014EP2708231A1 Combined treatment with netrin-1 interfering drug and chemotherapeutic drug
03/19/2014EP2708230A1 Composition for external skin use for inflammatory diseases
03/19/2014EP2708229A1 Non-aqueous patch
03/19/2014EP2708228A1 Eye wash compositions
03/19/2014EP2708147A1 Methods for increasing brain functionality using 2-fucosyl-lactose
03/19/2014EP2708146A1 Nutritional composition for pregnant women with a beneficial glucose and insulin profile
03/19/2014EP2708145A1 Methods for modulating corticosterone levels in psychologically stressed individuals
03/19/2014EP2707486A1 Diagnosis and treatment of friedreich's ataxia
03/19/2014EP2707485A1 Methods of modulating micrornas in the treatment of pulmonary arterial hypertension
03/19/2014EP2707396A1 "biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof"
03/19/2014EP2707379A1 The use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
03/19/2014EP2707372A2 Spiro-oxindole mdm2 antagonists
03/19/2014EP2707371A1 New hexahydropyrroloimidazolone compounds
03/19/2014EP2707370A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES
03/19/2014EP2707369A1 Compositions and methods for treating alzheimer's disease
03/19/2014EP2707368A1 Polymorph of linagliptin benzoate
03/19/2014EP2707367A1 Methods for preparing naphthyridines
03/19/2014EP2707366A1 L-proline and citric acid co-crystals of (2s, 3r, 4r, 5s, 6r )- 2- (3- ((5- (4-fluorophenyl)thiophen-2-yl) methyl) -4-methylphenyl)-6- (hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
03/19/2014EP2707365A1 Hepatitis c virus inhibitors
03/19/2014EP2707359A1 Substituted indazole derivatives active as kinase inhibitors
03/19/2014EP2707358A1 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
03/19/2014EP2707354A1 Quinone based nitric oxide donating compounds
03/19/2014EP2707348A1 Process of separating chiral isomers of chroman compounds and their derivatives and precursors
03/19/2014EP2707032A1 Implantable polymeric device for sustained release of sufentanil
03/19/2014EP2707031A2 Protein-active agent conjugates and method for preparing the same
03/19/2014EP2707030A1 Cancer treatments
03/19/2014EP2707017A1 Lixisenatide and metformin for treatment of diabetes type 2
03/19/2014EP2707016A1 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
03/19/2014EP2707015A1 Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
03/19/2014EP2707009A1 Antipyretics to enhance tolerability of vesicle-based vaccines
03/19/2014EP2707006A1 Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories
03/19/2014EP2707005A1 Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
03/19/2014EP2707004A1 Compounds for use in the treatment of feline retroviral infections
03/19/2014EP2707003A1 Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same
03/19/2014EP2707002A1 Treatment of mastitis
03/19/2014EP2707001A1 Method for treatment of solid malignancies including advanced or metastatic solid malignancies
03/19/2014EP2707000A2 Treatment and management of cns disorders
03/19/2014EP2706999A2 Selective heterocyclic sphingosine 1 phosphate receptor modulators
03/19/2014EP2706998A1 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
03/19/2014EP2706997A1 Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
03/19/2014EP2706996A1 Combination of a statin and a taxane for the treatment of gastric cancer
03/19/2014EP2706995A2 Small molecule inhibitors of trpa1
03/19/2014EP2706994A1 Pharmaceutical topical composition for use in the treatment and/or in the prevention of infections of skin lesions
03/19/2014EP2706993A1 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers
03/19/2014EP2706992A2 Anxiolytic effect of pterostilbene
03/19/2014EP2706991A1 Multiple antigen presenting immunogenic composition, and methods and uses thereof
03/19/2014EP2706990A1 Semuloparin for the prevention of venous thromboembolism in cancer patients receiving chemotherapy
03/19/2014EP2706986A1 New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
03/19/2014EP2706985A1 Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
03/19/2014EP2706983A1 Novel pharmaceutical formulation
03/19/2014EP2706982A2 Intranasal pharmaceutical dosage forms comprising naloxone
03/19/2014EP2706854A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptor agonists in combination with nicotine
03/19/2014EP2706853A1 Aminopyrimidines as syk inhibitors
03/19/2014EP2706852A1 Bipyridylaminopyridines as syk inhibitors
03/19/2014CN103649311A Oligonucleotide derivative, oligonucleotide derivative-containing pharmaceutical composition for treatment and pharmaceutical composition for diagnosis, and oligonucleotide derivative for regulation of miRNA function
03/19/2014CN103649128A Method for manufacturing hydroxyethyl starch derivatives
03/19/2014CN103649103A Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
03/19/2014CN103649098A Regulation of nitric oxide release and biofilm development
1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 7860